Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Thermo Fisher Scientific Inc NYSE: TMO-N

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

More stories below advertisement

Latest Press Releases

Thermo Fisher Scientific to Present at the BofA Securities 2021 Healthcare Conference on May 12, 2021
- PR Newswire - PRF - Mon May 10, 3:05PM CDT
PR Newswire - PRF - CMTX
Mon May 10, 3:05PM CDT
, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that , chairman, president and chief executive officer, will present virtually at the BofA Securities 2021 Health Care Conference on at .
Thermo Fisher Scientific Reports First Quarter 2021 Results
- PR Newswire - PRF - Thu Apr 29, 5:00AM CDT
PR Newswire - PRF - CMTX
Thu Apr 29, 5:00AM CDT
, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended .
PPD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PPD, Inc. - PPD
- BusinessWire - Mon Apr 19, 10:06PM CDT
BusinessWire - CMTX
Mon Apr 19, 10:06PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of PPD, Inc. (NasdaqGS: PPD) to Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the proposed transaction, shareholders of PPD will receive only $47.50 in cash for each share of PPD that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PPD, Inc. Buyout
- GlobeNewswire - Fri Apr 16, 11:48AM CDT
GlobeNewswire - CMTX
Fri Apr 16, 11:48AM CDT
EQNX::TICKER_START EQNX::TICKER_END
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of PPD, Inc. (Nasdaq - PPD)
- ACCESSWIRE - Thu Apr 15, 6:08PM CDT
ACCESSWIRE - CMTX
Thu Apr 15, 6:08PM CDT
BALA CYNWYD, PA / ACCESSWIRE / April 15, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PPD, Inc. ("PPD" or the "Company") (NASDAQ:PPD) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Thermo Fisher Scientific Inc. (NYSE:TMO) ("Thermo Fisher"). Under the terms of the agreement, PPD stockholders will receive only $47.50 for each share of PPD stock that they hold.
SHAREHOLDER ALERT: WeissLaw LLP Investigates PPD, Inc.
- PR Newswire - PRF - Thu Apr 15, 4:25PM CDT
PR Newswire - PRF - CMTX
Thu Apr 15, 4:25PM CDT
, /PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of PPD, Inc. ("PPD" or the "Company") (NASDAQ: PPD) in connection with the proposed acquisition of the Company by Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the merger agreement, PPD shareholders will receive in cash for each share of PPD common stock that they hold. The transaction is valued at approximately .
PPD ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PPD and Encourages Investors to Contact the Firm
- GlobeNewswire - Thu Apr 15, 12:38PM CDT
GlobeNewswire - CMTX
Thu Apr 15, 12:38PM CDT
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of PPD, Inc. (NASDAQ: PPD) breached their fiduciary duties or violated the federal securities laws in connection with the company's acquisition by Thermo Fisher Scientific Inc. (NYSE: TMO).
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
- PR Newswire - PRF - Thu Apr 15, 6:00AM CDT
PR Newswire - PRF - CMTX
Thu Apr 15, 6:00AM CDT
and , /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) (""), the world leader in serving science, and PPD, Inc. (Nasdaq: PPD) ("PPD"), a leading global provider of clinical research services to the pharma and biotech industry, today announced that their boards of directors have approved a definitive agreement under which will acquire PPD for per share for a total cash purchase price of plus the assumption of approximately of net debt. This represents a premium of approximately 24% to the unaffected closing price of PPD's common stock on the Nasdaq as of , or 32% to the 60-day VWAP inclusive of that date.
FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
- PR Newswire - PRF - Mon Apr 12, 7:00AM CDT
PR Newswire - PRF - CMTX
Mon Apr 12, 7:00AM CDT
, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit.
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 29, 2021
- PR Newswire - PRF - Mon Apr 5, 3:45PM CDT
PR Newswire - PRF - CMTX
Mon Apr 5, 3:45PM CDT
, /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2021 before the market opens on , and will hold a conference call on the same day at .

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies